Jiang Yuyan, Pu Kanyi
School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.
Adv Biosyst. 2018 May;2(5):e1700262. doi: 10.1002/adbi.201700262. Epub 2018 Mar 24.
Noninvasive near-infrared (NIR) light ranging from 650 to 1000 nm (NIR-I) is widely employed in fundamental research and clinical applications; however, a recently discovered second NIR (NIR-II) window from 1000 to 1700 nm exhibits even better deep-tissue imaging capability due to reduced photon scattering, minimized tissue autofluorescence, and increased applicable power at longer wavelengths. This review focuses on recent advances of organic contrast agents developed for in vivo fluorescence and photoacoustic imaging in the NIR-II optical window. The superiority of the NIR-II over the NIR-I window for molecular imaging is first discussed in detail, followed by discussion of fluorescence and photoacoustic imaging of cancer, vasculature, and the brain using organic contrast agents in the NIR-II window. At last, challenges and perspectives of organic contrast agents for NIR-II in vivo imaging are suggested.
波长范围在650至1000纳米的非侵入式近红外(NIR)光(NIR-I)被广泛应用于基础研究和临床应用;然而,最近发现的波长范围在1000至1700纳米的第二个近红外(NIR-II)窗口,由于光子散射减少、组织自发荧光最小化以及更长波长下适用功率增加,表现出更好的深层组织成像能力。本综述聚焦于为NIR-II光学窗口内的体内荧光和光声成像而开发的有机造影剂的最新进展。首先详细讨论了NIR-II相对于NIR-I窗口在分子成像方面的优势,随后讨论了使用NIR-II窗口内的有机造影剂对癌症、脉管系统和大脑进行的荧光和光声成像。最后,提出了用于NIR-II体内成像的有机造影剂面临的挑战和前景。